IP Library › Granted Patent US 10,081,812
Granted Patent B2
US 10,081,812 · App. 15/563,176 · Granted Sep 25, 2018

D-amino acid-inducible gene expression system for

Inventors: Lianghui Ji (Singapore, SG); Yanbin Liu (Singapore, SG); Chong Mei John Koh (Singapore, SG)
Assignee: TEMASEK LIFE SCIENCES LABORATORY LTD
C12N15/815C12N1/16C12N15/80C12N15/81C12N2830/36C12N2840/002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,081,812
App. No.
15/563,176
Granted
Sep 25, 2018
Kind
B2
Abstract

The present invention relates to the field of fungal biotechnology, more particularly to a strong inducible gene expression system in fungal species, such as a species of the Rhodosporidium genus or the Rhodotorula genus.

Claims (28)

1. A D-amino acid inducible gene expression system operable in a transgenic fungal cell comprising a nucleic acid construct comprising a D-amino acid inducible promoter operably linked to a heterologous polynucleotide, wherein the promoter is selected from the group consisting of:

(a) a promoter having at least 80% identity to the nucleotide sequence set forth in SEQ ID NO:94;

(b) a promoter having at least 80% identity to the nucleotide sequence set forth in SEQ ID NO:95;

(c) a promoter having at least 80% identity to the nucleotide sequence set forth in SEQ ID NO:96;

(d) a promoter having at least 80% identity to the nucleotide sequence set forth in SEQ ID NO:97; and

(e) a promoter having at least 80% identity to the nucleotide sequence set forth in SEQ ID NO:5, and

wherein the promoter comprises a promoter motif comprising the nucleotide sequence set forth in SEQ ID NO:6.

2. The expression system of claim 1 , wherein the fungal cell is a transgenic fungal cell of a species of Rhodsporidium genus or Rodottorula genus.

3. The expression system of claim 1 , wherein the transgenic fungal cell comprises a mutant D-amino acid oxidase gene having no or reduced D-amino acid oxidase activity compared to a fungal cell comprising a wild type D-amino acid oxidase gene.

4. The expression system of claim 1 , wherein the heterologous polynucleotide is operably linked to a transcription terminator.

5. The expression system of claim 1 , wherein the nucleic acid construct contains a nucleotide sequence having at least 75% identity to the nucleotide sequence set forth in SEQ ID NO:7.

6. The expression system of claim 5 , wherein the nucleotide sequence is an intron operably linked to the inducible promoter and operably linked to the heterologous polynucleotide.

7. The expression system of claim 5 , wherein the nucleotide sequence is an intron inserted into the 5′ region of the heterologous polynucleotide.

8. The expression system of claim 5 , wherein the nucleotide sequence is an intron inserted into the 5′ UTR of the inducible promoter.

9. The expression system of claim 5 , wherein the nucleotide sequence is part of the coding sequence of the heterologous polynucleotide.

10. The expression system of claim 5 , wherein the nucleotide sequence is selected from the group consisting of SEQ ID NO:56, SEQ ID NO:57, SEQ ID NO:58 and SEQ ID NO:59.

11. The expression system of claim 1 , wherein the heterologous polynucleotide encodes a protein of interest.

12. The expression system of claim 1 , wherein the heterologous polynucleotide encodes an RNA molecule for down regulating a target gene of interest.

13. A transgenic fungal cell comprising the expression system of claim 1 .

14. A composition comprising the transgenic fungal cell of claim 13 and a culture medium comprising a D-amino acid.

15. The composition of claim 14 , wherein the D-amino acid is D-alanine, D-threonine, D-serine, D-valine or D-proline.

16. The composition of claim 14 , wherein the concentration of the D-amino acid in the culture medium is from about 0.1 mM to about 100 mM.

17. A method for preparing a transgenic fungal cell comprising:

(a) introducing the expression system of claim 1 into a fungal cell and

(b) selecting a transgenic fungal cell which comprises the nucleic acid construct.

18. A method of inducible expression of a polynucleotide in a fungal cell comprising culturing the transgenic fungal cell of claim 13 in a culture medium comprising a D-amino acid to induce expression of the heterologous polynucleotide.

19. The method of claim 18 , wherein the D-amino acid is D-alanine, D-threonine, D-serine, D-valine or D-proline.

20. The method of claim 18 , wherein the concentration of the D-amino acid in the culture medium is from about 0.1 mM to about 100 mM.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2017
From: JI, LIANGHUI; LIU, YANBIN; KOH, CHONG MEI JOHN
To: TEMASEK LIFE SCIENCES LABORATORY LIMITED
Reel/Frame 043742/0617 →
Continuity (2)
Provisional Application 62142788 · Apr 3, 2015
Related Publication 20180073034A1 · Mar 15, 2018
Cited By (3)
US 12,305,206 US 12,305,207 US 12,509,709